Renaissance Technologies (RenTech)'s VERA Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 457,300 shares of Vera Therapeutics, Inc. (VERA) worth $18.4 M, representing 0.03% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in VERA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 263,900 shares. Largest reduction occurred in Q2 2023, reducing 174,800 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Vera Therapeutics (VERA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vera Therapeutics (VERA) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +263,900 | Add 136.45% | 457,300 | $40.23 |
| Q4 2025 | +193,400 | New Buy | 193,400 | $50.64 |
| Q2 2025 | -40,600 | Sold Out | 0 | $0.00 |
| Q1 2025 | +4,900 | Add 13.73% | 40,600 | $24.02 |
| Q4 2024 | +35,700 | New Buy | 35,700 | $42.29 |
| Q3 2024 | -147,800 | Sold Out | 0 | $0.00 |
| Q2 2024 | +32,800 | Add 28.52% | 147,800 | $36.18 |
| Q1 2024 | +115,000 | New Buy | 115,000 | $43.12 |
| Q4 2023 | -87,200 | Sold Out | 0 | $0.00 |
| Q3 2023 | +87,200 | New Buy | 87,200 | $13.72 |
| Q2 2023 | -174,800 | Sold Out | 0 | $0.00 |
| Q1 2023 | +149,900 | Add 602.01% | 174,800 | $0.01 |
| Q4 2022 | +24,900 | New Buy | 24,900 | $0.02 |
Renaissance Technologies (RenTech)'s Vera Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Vera Therapeutics, Inc. (VERA) in Q4 2022, acquiring 24,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Vera Therapeutics, Inc. (VERA) for 13 quarters since Q4 2022.
Renaissance Technologies (RenTech)'s largest addition to Vera Therapeutics, Inc. (VERA) was in Q1 2026, adding 457,300 shares worth $18.4 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 457,300 shares of Vera Therapeutics, Inc. (VERA), valued at approximately $18.4 M.
As of the Q1 2026 filing, Vera Therapeutics, Inc. (VERA) represents approximately 0.03% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Vera Therapeutics, Inc. (VERA) was 457,300 shares, as reported at the end of Q1 2026.